Product Information
ROPINIROLE HCL ER 6 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $1.3489 per EA under NDC 43547055603. Its NADAC has been published 196 times since Sep 28, 2022.
Strength
6 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547055603
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ROPINIROLEApproval Type
Generic (ANDA)
FDA Application
ANDA204413On Market Since
3/22/2022
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL ER 6 MG TABLET has been published 196 times since Sep 28, 2022, and over the history we have for it it has risen 37.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3489 per EA |
|---|---|
| All-time high | $1.6033 (Dec 14, 2022) |
| All-time low | $0.6239 (Oct 18, 2023) |
| 52-week high | $1.3489 |
| 52-week low | $0.9407 |
| Median price | $1.0948 |
| Average price | $1.1290 |
| Largest weekly change | +80.0% (Nov 22, 2023) |
| Weeks tracked | 196 |
| Tracking since | Sep 28, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the ropinirole market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL ER 6 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL ER 6 MG TABLET, manufactured by Solco Healthcare US LLC, is $1.3489 per EA (NDC 43547055603), effective Jun 24, 2026.
How has the price of ROPINIROLE HCL ER 6 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL ER 6 MG TABLET has risen 37.8%. It has been tracked across 196 weekly CMS publications since Sep 28, 2022.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL ER 6 MG TABLET?
Since Sep 28, 2022, the NADAC for ROPINIROLE HCL ER 6 MG TABLET has ranged from a low of $0.6239 (Oct 18, 2023) to a high of $1.6033 (Dec 14, 2022), with a median of $1.0948 per EA.
Are there cheaper alternatives to ROPINIROLE HCL ER 6 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ROPINIROLE HCL ER 6 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures ROPINIROLE HCL ER 6 MG TABLET?
ROPINIROLE HCL ER 6 MG TABLET (NDC 43547055603) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification